Skip to content
★ Sign in to follow
WG
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€1.4M

Latest filing published 14 Aug 2015 for ABIOMED INC.

Insider track record

Disclosed buys
0
Disclosed sells
6
Signal history

No signal scores available.

W. Gerald Austen: trading record in brief

All filings by W. Gerald Austen on record concern Abiomed Inc. The record holds 19 filings, for trades running from 20 July 2006 to 12 August 2015.

Sales make up the whole of the open-market record (6 sales, €1.4M). Besides market trades, the filings include 3 share grants and 10 option exercises. Since January 2015: no purchases and 2 sales on the market.

The newest entry dates from 14 August 2015: a share grant, in Abiomed Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to W. Gerald Austen

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    3,900 shares0Common Stock, $0.01 par valueSEC:0001179110-15-012157:0
  • ▼
    DirectorExecutivesAbiomed Inc
    363,720 USD0SEC
    6,000 shares@ US$60.62Common Stock, $0.01 par valueSEC:0001179110-15-003548:0
  • ▼
    DirectorExecutivesAbiomed Inc
    469,200 USD0SEC
    8,000 shares@ US$58.65Common Stock, $0.01 par valueSEC:0001179110-15-002822:0
  • ◇
    DirectorExecutivesAbiomed Inc
    223,560 USD0SEC
    12,000 shares@ US$18.63Common Stock, $0.01 par valueSEC:0001179110-15-000940:0
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    7,740 shares0Common Stock, $.01 par valueSEC:0001179110-14-012929:0
  • ◆
    DirectorExecutivesAbiomed Inc
    0SEC
    7,401 shares0Common Stock, $.01 par valueSEC:0001179110-14-004679:0
  • ◇
    DirectorExecutivesAbiomed Inc
    105,680 USD0SEC
    8,000 shares@ US$13.21Common Stock, $.01 par valueSEC:0001179110-14-002958:0
  • ▼
    DirectorExecutivesAbiomed Inc
    225,600 USD0SEC
    8,000 shares@ US$28.20Common Stock, $.01 par valueSEC:0001179110-14-002958:1
  • ◇
    DirectorExecutivesAbiomed Inc
    101,520 USD0SEC
    8,000 shares@ US$12.69Common Stock, $.01 par valueSEC:0001179110-13-016485:0
  • ▼
    DirectorExecutivesAbiomed Inc
    205,760 USD0SEC
    8,000 shares@ US$25.72Common Stock, $.01 par valueSEC:0001179110-13-016485:1
  • ◇
    DirectorExecutivesAbiomed Inc
    80,480 USD0SEC
    8,000 shares@ US$10.06Common Stock $.01 par valueSEC:0001179110-13-012808:0
  • ▼
    DirectorExecutivesAbiomed Inc
    182,800 USD0SEC
    8,000 shares@ US$22.85Common Stock, $0.01 par valueSEC:0001179110-13-012808:1
  • ▼
    DirectorExecutivesAbiomed Inc
    265,200 USD0SEC
    20,000 shares@ US$13.26Common Stock, $0.01 par valueSEC:0001179110-12-015782:0
  • ◇
    DirectorExecutivesAbiomed Inc
    83,280 USD0SEC
    8,000 shares@ US$10.41Common Stock, $0.01 par valueSEC:0001179110-12-011649:0
  • ◇
    DirectorExecutivesAbiomed Inc
    119,880 USD0SEC
    12,000 shares@ US$9.99Common Stock, $0.01 par valueSEC:0001179110-12-007998:0
  • ◇
    DirectorExecutivesAbiomed Inc
    92,040 USD0SEC
    12,000 shares@ US$7.67Common Stock, $0.01 par valueSEC:0001179110-11-015032:0
  • ◇
    DirectorExecutivesAbiomed Inc
    25,750 USD0SEC
    5,000 shares@ US$5.15Common Stock, $0.01 par valueSEC:0001179110-10-009728:0
  • ◇
    DirectorExecutivesAbiomed Inc
    23,550 USD0SEC
    5,000 shares@ US$4.71Common Stock, $0.01 par valueSEC:0001179110-10-009728:1
  • ◇
    DirectorExecutivesAbiomed Inc
    175,000 USD0SEC
    25,000 shares@ US$7.00Common Stock, $.01 par valueSEC:0001179110-06-015427:0

19 of 19 declarations